Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma
Magnetic Resonance in Medicine2013Vol. 71(5), pp. 1854–1862
Citations Over TimeTop 10% of 2013 papers
Inna V. Linnik, Marietta Scott, Katherine F. Holliday, Neil Woodhouse, John C. Waterton, James P.B. O’Connor, Hervé Barjat, Carsten Liess, Jose L. Ulloa, Helen Young, Caroline Dive, Cassandra L. Hodgkinson, Tim Ward, Darren L. Roberts, Samantha J. Mills, Gerard Thompson, Giovanni A. Buonaccorsi, Susan Cheung, Alan Jackson, Josephine H. Naish, Geoff J.M. Parker
Abstract
These data support further investigation of T1 -weighted OE-MRI to identify regional tumor hypoxia. The quantification of AUCOE has translational potential as a clinical biomarker of hypoxia.
Related Papers
- → Oxygen-Enhanced MRI Accurately Identifies, Quantifies, and Maps Tumor Hypoxia in Preclinical Cancer Models(2015)158 cited
- → Correlative analyses between tissue-based hypoxia biomarkers and hypoxia PET imaging in head and neck cancer patients during radiochemotherapy—results from a prospective trial(2019)43 cited
- → Tumor hypoxia: a new PET imaging biomarker in clinical oncology(2015)38 cited
- → TH-CD-204-05: Developing a Non-Invasive MRI Prognostic Biomarker to Predict Response to Hypofractionated Radiotherapy(2015)
- → Biomarker for Radiation Therapy: The Relationship Between Tissue Oxygenation and Redox Status(2017)